(FHI) Federated Investors - Overview
Sector: Financial ServicesIndustry: Asset Management | Exchange NYSE (USA) | Currency USD | Market Cap: 4.361m | Total Return 39.7% in 12m
Stock: Investment Funds, Asset Management, Fixed Income, Equity
Total Rating 77
Risk 80
Buy Signal -0.56
| Risk 5d forecast | |
|---|---|
| Volatility | 23.2% |
| Relative Tail Risk | 2.98% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.40 |
| Alpha | 28.83 |
| Character TTM | |
|---|---|
| Beta | 0.664 |
| Beta Downside | 1.172 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.61% |
| CAGR/Max DD | 0.56 |
EPS (Earnings per Share)
Revenue
Description: FHI Federated Investors March 05, 2026
Federated Hermes, Inc. (FHI) is an investment manager serving a diverse client base, including individuals, institutions, and government entities.
The firm manages various investment products, such as mutual funds and separate accounts, across equity, fixed income, and money market strategies. Asset management firms typically generate revenue through management fees, calculated as a percentage of assets under management.
FHI invests globally in public equity and fixed income markets, utilizing both fundamental and quantitative analysis. The investment management industry is highly competitive, with firms differentiating themselves through investment performance, product offerings, and distribution channels.
For more detailed financial insights and performance metrics, further research on ValueRay is recommended.
Headlines to watch out for
- Money market fund demand impacts assets under management
- Equity and fixed income market performance affects fee revenue
- Regulatory changes in investment management pose compliance risks
- Interest rate fluctuations influence money market fund profitability
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 404.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA -3.87 > 1.0 |
| NWC/Revenue: 44.94% < 20% (prev 30.16%; Δ 14.79% < -1%) |
| CFO/TA 0.13 > 3% & CFO 297.3m > Net Income 404.1m |
| Net Debt (-126.9m) to EBITDA (576.0m): -0.22 < 3 |
| Current Ratio: 41.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (73.8m) vs 12m ago -5.75% < -2% |
| Gross Margin: 68.63% > 18% (prev 0.67%; Δ 6.80k% > 0.5%) |
| Asset Turnover: 82.51% > 50% (prev 78.29%; Δ 4.22% > 0%) |
| Interest Coverage Ratio: 43.49 > 6 (EBITDA TTM 576.0m / Interest Expense TTM 12.7m) |
Altman Z'' 8.32
| A: 0.35 (Total Current Assets 831.3m - Total Current Liabilities 20.1m) / Total Assets 2.29b |
| B: 0.67 (Retained Earnings 1.53b / Total Assets 2.29b) |
| C: 0.25 (EBIT TTM 553.8m / Avg Total Assets 2.19b) |
| D: 2.02 (Book Value of Equity 2.07b / Total Liabilities 1.03b) |
| Altman-Z'' Score: 8.32 = AAA |
Beneish M -2.98
| DSRI: 0.90 (Receivables 105.7m/106.2m, Revenue 1.80b/1.63b) |
| GMI: 0.97 (GM 68.63% / 66.88%) |
| AQI: 1.04 (AQ_t 0.58 / AQ_t-1 0.56) |
| SGI: 1.11 (Revenue 1.80b / 1.63b) |
| TATA: 0.05 (NI 404.1m - CFO 297.3m) / TA 2.29b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of FHI shares?
As of March 28, 2026, the stock is trading at USD 56.00 with a total of 484,751 shares traded.
Over the past week, the price has changed by +0.59%, over one month by -0.02%, over three months by +4.65% and over the past year by +39.73%.
Over the past week, the price has changed by +0.59%, over one month by -0.02%, over three months by +4.65% and over the past year by +39.73%.
Is FHI a buy, sell or hold?
Federated Investors has received a consensus analysts rating of 3.13.
Therefor, it is recommend to hold FHI.
- StrongBuy: 1
- Buy: 0
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the FHI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 55.6 | -0.8% |
| Analysts Target Price | 55.6 | -0.8% |
FHI Fundamental Data Overview March 27, 2026
P/E Trailing = 11.2086
P/E Forward = 10.917
P/S = 2.4218
P/B = 3.5336
P/EG = 1.0851
Revenue TTM = 1.80b USD
EBIT TTM = 553.8m USD
EBITDA TTM = 576.0m USD
Long Term Debt = 348.4m USD (from longTermDebt, last quarter)
Short Term Debt = 20.1m USD (from shortTermDebt, last quarter)
Debt = 457.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -126.9m USD (from netDebt column, last quarter)
Enterprise Value = 4.09b USD (4.36b + Debt 457.0m - CCE 725.6m)
Interest Coverage Ratio = 43.49 (Ebit TTM 553.8m / Interest Expense TTM 12.7m)
EV/FCF = 14.04x (Enterprise Value 4.09b / FCF TTM 291.4m)
FCF Yield = 7.12% (FCF TTM 291.4m / Enterprise Value 4.09b)
FCF Margin = 16.15% (FCF TTM 291.4m / Revenue TTM 1.80b)
Net Margin = 22.39% (Net Income TTM 404.1m / Revenue TTM 1.80b)
Gross Margin = 68.63% ((Revenue TTM 1.80b - Cost of Revenue TTM 566.2m) / Revenue TTM)
Gross Margin QoQ = 72.59% (prev 69.21%)
Tobins Q-Ratio = 1.79 (Enterprise Value 4.09b / Total Assets 2.29b)
Interest Expense / Debt = 0.70% (Interest Expense 3.20m / Debt 457.0m)
Taxrate = 23.44% (32.9m / 140.3m)
NOPAT = 423.9m (EBIT 553.8m * (1 - 23.44%))
Current Ratio = 41.26 (Total Current Assets 831.3m / Total Current Liabilities 20.1m)
Debt / Equity = 0.38 (Debt 457.0m / totalStockholderEquity, last quarter 1.20b)
Debt / EBITDA = -0.22 (Net Debt -126.9m / EBITDA 576.0m)
Debt / FCF = -0.44 (Net Debt -126.9m / FCF TTM 291.4m)
Total Stockholder Equity = 1.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.47% (Net Income 404.1m / Total Assets 2.29b)
RoE = 35.33% (Net Income TTM 404.1m / Total Stockholder Equity 1.14b)
RoCE = 37.12% (EBIT 553.8m / Capital Employed (Equity 1.14b + L.T.Debt 348.4m))
RoIC = 28.42% (NOPAT 423.9m / Invested Capital 1.49b)
WACC = 7.58% (E(4.36b)/V(4.82b) * Re(8.32%) + D(457.0m)/V(4.82b) * Rd(0.70%) * (1-Tc(0.23)))
Discount Rate = 8.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.12%
[DCF] Terminal Value 80.87% ; FCFF base≈313.3m ; Y1≈333.4m ; Y5≈400.6m
[DCF] Fair Price = 103.6 (EV 7.73b - Net Debt -126.9m = Equity 7.85b / Shares 75.8m; r=7.58% [WACC]; 5y FCF grow 7.12% → 3.0% )
EPS Correlation: 43.38 | EPS CAGR: 24.56% | SUE: 0.67 | # QB: 0
Revenue Correlation: 87.24 | Revenue CAGR: 11.41% | SUE: 2.43 | # QB: 2
EPS next Quarter (2026-06-30): EPS=1.21 | Chg7d=-0.010 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=5
EPS current Year (2026-12-31): EPS=5.16 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=-1 | Growth EPS=+0.6% | Growth Revenue=+8.6%
EPS next Year (2027-12-31): EPS=5.71 | Chg7d=+0.007 | Chg30d=+0.007 | Revisions Net=+1 | Growth EPS=+10.6% | Growth Revenue=+4.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -0.6% (Discount Rate 8.3% - Earnings Yield 8.9%)
[Growth] Growth Spread = +14.7% (Analyst 14.1% - Implied -0.6%)
P/E Forward = 10.917
P/S = 2.4218
P/B = 3.5336
P/EG = 1.0851
Revenue TTM = 1.80b USD
EBIT TTM = 553.8m USD
EBITDA TTM = 576.0m USD
Long Term Debt = 348.4m USD (from longTermDebt, last quarter)
Short Term Debt = 20.1m USD (from shortTermDebt, last quarter)
Debt = 457.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -126.9m USD (from netDebt column, last quarter)
Enterprise Value = 4.09b USD (4.36b + Debt 457.0m - CCE 725.6m)
Interest Coverage Ratio = 43.49 (Ebit TTM 553.8m / Interest Expense TTM 12.7m)
EV/FCF = 14.04x (Enterprise Value 4.09b / FCF TTM 291.4m)
FCF Yield = 7.12% (FCF TTM 291.4m / Enterprise Value 4.09b)
FCF Margin = 16.15% (FCF TTM 291.4m / Revenue TTM 1.80b)
Net Margin = 22.39% (Net Income TTM 404.1m / Revenue TTM 1.80b)
Gross Margin = 68.63% ((Revenue TTM 1.80b - Cost of Revenue TTM 566.2m) / Revenue TTM)
Gross Margin QoQ = 72.59% (prev 69.21%)
Tobins Q-Ratio = 1.79 (Enterprise Value 4.09b / Total Assets 2.29b)
Interest Expense / Debt = 0.70% (Interest Expense 3.20m / Debt 457.0m)
Taxrate = 23.44% (32.9m / 140.3m)
NOPAT = 423.9m (EBIT 553.8m * (1 - 23.44%))
Current Ratio = 41.26 (Total Current Assets 831.3m / Total Current Liabilities 20.1m)
Debt / Equity = 0.38 (Debt 457.0m / totalStockholderEquity, last quarter 1.20b)
Debt / EBITDA = -0.22 (Net Debt -126.9m / EBITDA 576.0m)
Debt / FCF = -0.44 (Net Debt -126.9m / FCF TTM 291.4m)
Total Stockholder Equity = 1.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.47% (Net Income 404.1m / Total Assets 2.29b)
RoE = 35.33% (Net Income TTM 404.1m / Total Stockholder Equity 1.14b)
RoCE = 37.12% (EBIT 553.8m / Capital Employed (Equity 1.14b + L.T.Debt 348.4m))
RoIC = 28.42% (NOPAT 423.9m / Invested Capital 1.49b)
WACC = 7.58% (E(4.36b)/V(4.82b) * Re(8.32%) + D(457.0m)/V(4.82b) * Rd(0.70%) * (1-Tc(0.23)))
Discount Rate = 8.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.12%
[DCF] Terminal Value 80.87% ; FCFF base≈313.3m ; Y1≈333.4m ; Y5≈400.6m
[DCF] Fair Price = 103.6 (EV 7.73b - Net Debt -126.9m = Equity 7.85b / Shares 75.8m; r=7.58% [WACC]; 5y FCF grow 7.12% → 3.0% )
EPS Correlation: 43.38 | EPS CAGR: 24.56% | SUE: 0.67 | # QB: 0
Revenue Correlation: 87.24 | Revenue CAGR: 11.41% | SUE: 2.43 | # QB: 2
EPS next Quarter (2026-06-30): EPS=1.21 | Chg7d=-0.010 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=5
EPS current Year (2026-12-31): EPS=5.16 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=-1 | Growth EPS=+0.6% | Growth Revenue=+8.6%
EPS next Year (2027-12-31): EPS=5.71 | Chg7d=+0.007 | Chg30d=+0.007 | Revisions Net=+1 | Growth EPS=+10.6% | Growth Revenue=+4.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -0.6% (Discount Rate 8.3% - Earnings Yield 8.9%)
[Growth] Growth Spread = +14.7% (Analyst 14.1% - Implied -0.6%)